Data / Form D filings / Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc.: Form D filings
Reviva Pharmaceuticals, Inc., a pharmaceuticals company in Santa Clara, CA, filed 4 Form D notices with the SEC between 2012 and 2016. The latest, on July 25, 2016, reports $1.2 million sold of a $5 million offering to 16 investors.
Find out what Reviva Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3900 Freedom Circle, #101, Santa Clara, CA, 95054
- Phone
- (408) 960-2209
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1552470
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 25, 2016 | New notice | $5,000,000 | $1,154,087 | $3,845,913 | 16 | Jul 11, 2016 | sec.gov |
| Jun 25, 2014 | New notice | $15,831,541 | $15,831,541 | $0 | 47 | Jun 12, 2014 | sec.gov |
| Mar 21, 2013 | New notice | $12,039,776 | $12,039,776 | $0 | 82 | Mar 7, 2013 | sec.gov |
| Aug 20, 2012 | New notice | $7,624,840 | $7,624,840 | $0 | 71 | Jan 5, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Laxminarayan Bhat | Executive Officer, Director | |
| Marc Cantillon | Executive Officer | |
| Sarvajna Dwivedi | Director | |
| Pedr Jensen | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 25, 2016 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Reviva Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.